首页 | 本学科首页   官方微博 | 高级检索  
     


Disclosure of incidental findings in cancer genomic research: investigators' perceptions on obligations and barriers
Authors:E. Kleiderman  D. Avard  A. Besso  S. Ali‐Khan  G. Sauvageau  J. Hébert
Affiliation:1. Centre of Genomics and Policy, McGill University, Montreal, Quebec, Canada;2. Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Quebec, Canada;3. Leukemia Cell Bank of Quebec and Division of Hematology‐Oncology, H?pital Maisonneuve‐Rosemont, Montreal, Quebec, Canada;4. Department of Medicine, Université de Montréal, Montreal, Quebec, Canada
Abstract:Although there has been significant research surrounding incidental findings (IFs), the guidelines and information provided to investigators remain unspecific, unclear, and often generalize the course of action to everyone in the field. We explored the perceptions and experiences of investigators regarding the return of IFs in genetic research. Researchers and clinician‐researchers were invited to participate in semi‐structured telephone interviews in Quebec and Ontario. Twenty professionals participated, and thematic analysis was used to analyze the transcriptions. Four contextual elements emerged: (i) degree of significance of results, (ii) respect for persons, (iii) infrastructure implications, and (iv) professional responsibilities. Our findings demonstrate that all investigators raised similar contextual elements surrounding the return of IFs. However, some nuances in participants' experiences of the understanding of professional responsibilities also emerged. Because of the existing nuances, a one‐size‐fits‐all approach is inappropriate, suggesting that context ought to be considered in decisions about IFs.
Keywords:bioethics  cancer research  genetics  genomics  incidental findings  investigator duties  research ethics  return of results
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号